ArticleOcular oncology and pathology2017
Monte Carlo Estimation of Absorbed Dose Distributions Obtained from Heterogeneous
Article in Ocular oncology and pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 18 citations in OpenAlex.
- Evaluation of a water phantom detector-applicator setup for independent experimental verification ofMedical physics · 2026Article
- Independent verification of vendor-issued dosimetric data forMedical physics · 2026Article
- Quantifying the effect of eccentric ruthenium plaque placement on tumor volume dose.Journal of contemporary brachytherapy · 2023Article
- Modified Geometry ofJournal of personalized medicine · 2022Article
- Monte Carlo simulation of tilted contact plaque brachytherapy placement for juxtapapillary retinoblastoma.Radiation oncology (London, England) · 2022Article
- Monte Carlo Computation of Dose-Volume Histograms in Structures at Risk of an Eye Irradiated with Heterogeneous Ruthenium-106 Plaques.Ocular oncology and pathology · 2020Article
- Predicting Visual Acuity Deterioration and Radiation-Induced Toxicities after Brachytherapy for Choroidal Melanomas.Cancers · 2019Article
- Monte Carlo Simulation of the Treatment of Uveal Melanoma Using Measured HeterogeneousOcular oncology and pathology · 2019Article
- Dose Distributions and Treatment Margins in Ocular Brachytherapy with 106Ru Eye Plaques.Ocular oncology and pathology · 2018Article
- Inhomogeneous Surface Dose Distributions ofOcular oncology and pathology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe distribution of the emitter substance in
methodsBy Monte Carlo simulation of radiation transport, we study the absorbed dose distribution obtained from the specific CCA1364 and CCB1256
resultsThe largest discrepancy in depth dose distribution observed between the heterogeneous and the homogeneous plaques was 7.9 and 23.7% for the CCA and CCB plaques, respectively. In terms of isodose lines, the line referring to 100% of the reference dose penetrates 0.2 and 1.8 mm deeper in the case of heterogeneous CCA and CCB plaques, respectively, with respect to the homogeneous counterpart.
conclusionsThe observed differences in absorbed dose distributions obtained from heterogeneous and homogeneous plaques are clinically irrelevant if the plaques are used with a lateral safety margin of at least 2 mm. However, these differences may be relevant if the plaques are used in eccentric positioning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.